Related Experiment Video
Updated: Jun 27, 2026

Quantitation of Endothelial Cell Adhesiveness In Vitro
Published on: June 18, 2015
In vitro cell aggregation and cell adhesion molecules in Crohn's disease
L Mishra1, B B Mishra, M Harris
1Department of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Researchers developed an in vitro model to study Crohn's disease granulomas. The size of these cell aggregates correlates with disease activity, suggesting a role for cell adhesion molecules in granuloma formation.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Understanding Crohn's disease pathogenesis is limited by the absence of suitable models for inflammation and granuloma formation.
- Granulomas are key pathological features in Crohn's disease, but their in vivo formation mechanisms remain unclear.
Purpose of the Study:
- To develop and characterize an in vitro model of granuloma formation using peripheral blood mononuclear cells.
- To assess the correlation between the size of in vitro aggregates and the clinical activity of Crohn's disease.
- To investigate the role of cell adhesion molecules in the formation of these in vitro granuloma-like structures.
Main Methods:
- Peripheral blood mononuclear cells were cultured with polyacrylamide beads to form granuloma-like aggregates.
- Morphological and immunohistological analyses were performed on the in vitro aggregates.
- Blocking antibodies against specific cell adhesion molecules (LFA-2, LFA-3, Mac-1) were used to assess their role in aggregate formation.
- The size of in vitro aggregates was correlated with clinical disease activity.
Main Results:
- In vitro aggregates exhibited gross morphology and immunohistological features similar to in vivo Crohn's disease granulomas.
- A significant correlation was observed between the size of in vitro aggregates and the clinical activity of Crohn's disease (P < 0.001).
- Blocking antibodies against leukocyte function associated antigen LFA-2 (CD2), LFA-3 (CD58), and Mac-1 (CD11b/CD18) significantly inhibited in vitro aggregate formation.
Conclusions:
- The developed in vitro system effectively models the size and organization of in vivo granulomas found in Crohn's disease.
- Cell adhesion molecules, including CD2, CD58, and CD11b/CD18, are implicated in the process of granuloma formation in Crohn's disease.
- This model provides a valuable tool for further research into the molecular mechanisms underlying Crohn's disease pathogenesis.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease

